ValenTx Raises $22 Million
ValenTx Inc., a Carpinteria, Calif.-based developer of minimally-invasive treatments for morbid obesity, has raised $22 million in Series B funding. SV Life Sciences led the round, and was joined by Covidien Ventures and return backers EDF Ventures, Affinity Capital Management, Kaiser Permanente Ventures, TGap Ventures and Sapient Capital Management.
8 September 2009•2 mins read
